KCNK13
Potassium channel subfamily K member 13
Also known as: K2p13.1, KCNKD_HUMAN, THIK-1, THIK1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HB14
- Gene
- KCNK13
- Ensembl
- ENSG00000152315
- Chromosome
- 14
- Canonical length
- 408 aa
- Protein class
- Predicted membrane proteins, Voltage-gated ion channels
- Subcellular location
- Nuclear speckles,Cell Junctions
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a potassium channel containing two pore-forming domains. This protein is an open channel that can be stimulated by arachidonic acid and inhibited by the anesthetic halothane. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
408 residues, UniProt reviewed canonical sequence.
>Q9HB14|KCNK13
1 MAGRGFSWGP GHLNEDNARF LLLAALIVLY LLGGAAVFSA LELAHERQAK QRWEERLANF
61 SRGHNLSRDE LRGFLRHYEE ATRAGIRVDN VRPRWDFTGA FYFVGTVVST IGFGMTTPAT
121 VGGKIFLIFY GLVGCSSTIL FFNLFLERLI TIIAYIMKSC HQRQLRRRGA LPQESLKDAG
181 QCEVDSLAGW KPSVYYVMLI LCTASILISC CASAMYTPIE GWSYFDSLYF CFVAFSTIGF
241 GDLVSSQNAH YESQGLYRFA NFVFILMGVC CIYSLFNVIS ILIKQSLNWI LRKMDSGCCP
301 QCQRGLLRSR RNVVMPGSVR NRCNISIETD GVAESDTDGR RLSGEMISMK DLLAANKASL
361 AILQKQLSEM ANGCPHQTST LARDNEFSGG VGAFAIMNNR LAETSGDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNK13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 9.5 nTPM
Expression across tissuesHPA
Tissue
- testis: 9.5 nTPM
- parathyroid gland: 5.7 nTPM
- choroid plexus: 4.1 nTPM
- kidney: 4 nTPM
- thyroid gland: 1.8 nTPM
- heart muscle: 1.7 nTPM
Single-cell type
- sertoli cells: 300 nCPM
- microglia: 266 nCPM
- choroid plexus epithelial cells: 265 nCPM
- renal connecting tubule cells: 128 nCPM
- cdc: 76 nCPM
- ependymal cells: 75 nCPM
Immune cell
- myeloid DC: 1.2 nTPM
- classical monocyte: 0.4 nTPM
- intermediate monocyte: 0.4 nTPM
- naive CD8 T-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- choroid plexus: 12 nTPM
- white matter: 7.1 nTPM
- midbrain: 4.9 nTPM
- thalamus: 4.9 nTPM
- cerebral cortex: 4 nTPM
- spinal cord: 4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNK13.
Disease | ImmuneIEDB
Conditions an epitope on KCNK13 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 0.74
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- potassium ion transmembrane transport
- regulation of NLRP3 inflammasome complex assembly
- regulation of resting membrane potential
- regulation of excitatory synapse pruning
Molecular functions
- identical protein binding
- metal ion binding
- outward rectifier potassium channel activity
- potassium channel activity
- potassium ion leak channel activity
- protein heterodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNK13 as an antibody target. Whether an autoantibody or antibody against KCNK13 could matter depends on whether native KCNK13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNK13 is annotated at the cell surface, where native KCNK13 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNK13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...